
Castle Biosciences CSTL
$ 39.13
-0.67%
Quarterly report 2025-Q3
added 11-03-2025
Castle Biosciences P/E Ratio 2011-2025 | CSTL
Annual P/E Ratio Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.9 | -11.4 | -9.84 | -34.4 | -123 | 48.9 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 48.9 | -123 | -15.2 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 19.0 | -1.91 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 20.67 | -2.38 % | $ 222 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.23 | -4.21 % | $ 6.75 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
39 | $ 230.67 | 0.14 % | $ 169 B | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.56 | 5.18 % | $ 300 M | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.5 | -1.24 % | $ 1.91 M | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 101.86 | 0.29 % | $ 18.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
90.1 | $ 67.82 | 0.36 % | $ 26.2 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.63 | -0.34 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 19.07 | -2.13 % | $ 1.03 B | ||
|
Celcuity
CELC
|
-3.57 | $ 101.03 | -1.19 % | $ 3.99 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-0.00564 | $ 3.18 | -0.49 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
26 | $ 226.77 | -0.06 % | $ 41.1 B | ||
|
Guardant Health
GH
|
-13.4 | $ 101.71 | -1.23 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 7.22 | 1.26 % | $ 1.57 B | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 6.34 | -2.24 % | $ 574 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 4.84 | -4.72 % | $ 2.6 M | ||
|
National Research Corporation
NRC
|
32.6 | $ 18.99 | 1.74 % | $ 466 M | ||
|
Illumina
ILMN
|
-13.4 | $ 134.1 | -0.63 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
385 | $ 202.95 | -0.29 % | $ 10.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.27 | 0.61 % | $ 20 B | ||
|
Personalis
PSNL
|
-3.12 | $ 8.04 | -1.29 % | $ 476 M | ||
|
Quidel Corporation
QDEL
|
13 | $ 29.17 | -0.44 % | $ 1.23 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 175.53 | -0.24 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.84 | 0.22 % | $ 887 M | ||
|
RadNet
RDNT
|
1.32 K | $ 73.13 | -0.03 % | $ 5.34 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 253.05 | -0.36 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 182.3 | -0.29 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 684.48 | -0.58 % | $ 56.4 B | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 66.89 | 0.27 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
34.6 | $ 1 414.37 | -0.42 % | $ 30 B | ||
|
Agilent Technologies
A
|
34.7 | $ 137.94 | -0.33 % | $ 41.9 B |